Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in overweight and obese men

Asian Journal of Sports Medicine

Volumn 1, Issue 3, 2010, Pages 151-158

  Saremi, Abbas ^a   Shavandi, Nader ^a   Parastesh, Mohammad ^a   Daneshmand, Hassan ^a  

^a ARAK UNIVERSITY   (Iran)

Author keywords

Chemerin; Exercise; Metabolic syndrome; Obesity; Training

Indexed keywords

EID: 84874022823     PISSN: 2008000X     EISSN: 20087209     Source Type: Journal    
DOI: 10.5812/asjsm.34860     Document Type: Article

References (29)

1. Compher C, Badellino KO. Obesity and inflammation: lessons from bariatric surgery. J Parenter Enteral Nutr. 2008;32:645-7.
2. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118:2992-3002.
3. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821-30.
4. Cancello R, Clément K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG. 2006;113:1141-7.
5. Fernández-Veledo S, Nieto-Vazquez I, Vila-Bedmar R, et al. Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach. Arch Physiol Biochem. 2009;115:227-39.
6. Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007;282:28175-88.
7. MacDougald OA, Burant CF. The rapidly expandingfamily of adipokines. Cell Metab. 2007;6:159-61.
8. Zabel BA, Ohyama T, Zuniga L, et al. Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. Exp Hematol. 2006;34:1106-14.
9. Roh SG, Song SH, Choi KC, et al. Chemerin--a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun. 2007;362:1013-1018.
10. Wang LY, Wei L, Yu HY, et al. Relationship of serum chemerin to obesity and type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi. 2009;89:235-8.
11. Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cell. Diabetes. 2009;58:2731-40.
12. Bozaoglu K, Segal D, Shields KA, et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab. 2009;94:3085-8.
13. Venables MC, Jeukendrup AE. Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes Metab Res Rev. 2009;25:S18-23.
14. O'Leary VB, Marchetti CM, Krishnan RK, et al. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol. 2006;100:1584-9.
15. Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 2008;94:206-18.
16. Ostergard T, Jessen N, Schmitz O, et al. The effect of exercise, training, and inactivity on insulin sensitivity in diabetics and their relatives: what is new? Appl Physiol Nutr Metab. 2007;32:541-8.
17. You T, Nicklas BJ. Effects of exercise on adipokines and the metabolic syndrome. Curr Diab Rep. 2008;8:7-11.
18. Ibanez J, Izquierdo M, Argüelles I, et al. Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes Care. 2005;28:662-7.
19. Antuna-Puente B, Feve B, Fellahi S, et al. Adipokines: the link between insulin resistance and obesity. Diabetes & Metabolism. 2008;34:2-11.
20. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med. 2008;14:741-51.
21. Lazarevic G, Antic S, Cvetkovic T, et al. Effects of regular exercise on cardiovascular risk factors profile and oxidative stress in obese type 2 diabetic patients in regard to SCORE risk. Acta Cardiol. 2008;63:485-91.
22. Chang LC, Huang KC, Wu YW, et al. The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc. 2009;108:353-66.
23. Davidson LE, Hudson R, Kilpatrick K, et al. Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial. Arch Intern Med. 2009;69:122-31.
24. Prasad DS, Das BC. Physical inactivity: a cardiovascular risk factor. Indian J Med Sci. 2009;63:33-42.
25. Kamijo T, Murakami M. Regular physical exercise improves physical motor functions and biochemical markers in middle-age and elderly women. J Phys Act Health. 2009;6:55-62.
26. Slentz CA, Duscha BD, Johnson JL, et al. Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE-a randomized controlled study. Arch Intern Med. 2004;164:31-9.
27. Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obese Res. 2004;12:789-98.
28. Hajer GR, Van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959-71.
29. Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54:2277-86.